Your browser doesn't support javascript.
loading
Low-Molecular-Weight Heparin Is Superior to Aspirin in the Prevention of Thromboembolic Disease: Or Is It?
Parvizi, Javad; DeMik, David E; Dunbar, Michael; Hozack, William J; Mont, Michael A; Lachiewicz, Paul F.
Affiliation
  • Parvizi J; Rothman Orthopaedic Institute, Philadelphia, Pennsylvania.
  • DeMik DE; Rothman Orthopaedic Institute, Philadelphia, Pennsylvania.
  • Dunbar M; Dalhousie University, Halifax, Nova Scotia, Canada.
  • Hozack WJ; Rothman Orthopaedic Institute, Philadelphia, Pennsylvania.
  • Mont MA; Rubin Institute for Advanced Orthopedics, Sinai Hospital of Baltimore, Baltimore, Maryland.
  • Lachiewicz PF; Duke University, Durham, North Carolina.
J Bone Joint Surg Am ; 104(23): 2045-2046, 2022 12 07.
Article in En | MEDLINE | ID: mdl-36476736
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thromboembolism / Heparin, Low-Molecular-Weight Aspects: Patient_preference Limits: Humans Language: En Journal: J Bone Joint Surg Am Year: 2022 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thromboembolism / Heparin, Low-Molecular-Weight Aspects: Patient_preference Limits: Humans Language: En Journal: J Bone Joint Surg Am Year: 2022 Document type: Article Country of publication: United States